Lipocine Starts Phase 3 BLOOM Study of Oral Brexan...
Category : Clinical Trial Update 15 September 2026New Phase 3 Study Will Evaluate 48-Hour At-Home Treatment Lipocine Inc. has announced the start o...
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
New Phase 3 Study Will Evaluate 48-Hour At-Home Treatment Lipocine Inc. has announced the start o...
Study Will Evaluate Isavuconazonium Sulfate in Pediatric Patients Asahi Kasei Therapeutics Corp....
Phase 1 Study Shows Favorable Safety and Lung Exposure Agomab Therapeutics NV has reported positi...
CDSCO Expert Panel Reviews Sovateltide Clinical Trial Protocol Sun Pharma Laboratories Limited ha...
Global Clinical Trial Begins for Rare Sanfilippo Syndrome Type B MEDIPAL HOLDINGS CORPORATION and...